While breast cancer incidence rates are still on the rise, mortality rates keep decreasing, although at slower pace than in past. This is one of the take-home messages from Breast Cancer Statistics 2019-2020, the biennial [more]
Traditional approaches to generating clinical evidence rely on recruiting large numbers of patients into trials. Paolo Bruzzi reflects on the challenges of designing and analysing clinical trials in rare cancers, and reviews the potential for [more]
Some commonly used statistical concepts are hard to master not only for most patients, but for many professionals as well. Especially when it comes to cancer screening A common assumption, when addressing informed decision making [more]
The Cancer World team hopes that all our readers have had a good start to 2018. We look forward to bringing you critical, independent and rounded coverage of the big stories affecting quality cancer care [more]
Cancer, genetics, “bad luck” and prevention through lifestyle: two years after their first study that tried to quantify the random mutations that accumulate during stem cell divisions in healthy cells and drive cancer in different [more]
Eurocare, the landmark series of studies comparing survival of cancer patients among European countries, has been profoundly important in focusing attention on the quality of Europe’s cancer services over the past two decades. Now in [more]
If Tomasetti and Vogelstein had not used the words bad luck in their paper on how variation in cancer risk among tissues can be explained by the number of stem cell divisions, the media might [more]
Joining a clinical trial can be a lifeline for patients with few options open to them. But are outdated attitudes and practices preventing them from benefiting as much as they could? The transformation in the [more]
This editorial looks at how to present statistical information in a way that is easy for readers to interpret and apply, and calls on everyone involved writing educational material and press releases to make a [more]